The British Veterinary Association has announced that it has almost halved the cost of attending its annual Congress this September.
According to the BVA, the decision was made to demonstrate its commitment to providing high-quality, affordable CPD.
The two-day event will now cost £150 +VAT for members and £300 +VAT for non-members for up to 11 hours of small animal CPD provided by the University of Liverpool.
The choice of topics includes:
The BVA says all the lectures will be delivered by leading experts in their field.
Alongside the clinical CPD programme BVA will run its contentious issues stream with discussions around the impact of women on the profession, horses for sport and the use of antimicrobials.
BVA Past President and small animal vet Harvey Locke worked with the University of Liverpool to create the clinical CPD programme. He said: "With a small animal clinical programme provided by the University of Liverpool, the BVA this year not only provides world-class CPD at Congress but it also comes at a fantastic price.
"BVA is committed to providing high-quality CPD to our members at affordable rates. We look forward to welcoming vets to Liverpool in September for our great value CPD programme."
BVA Congress takes place in Liverpool on 27-29 September at the Merseyside Maritime Museum.
The full programme and further information is available at www.bva.co.uk/congress.
The module, which accounts for one hour’s CPD, is facilitated by a Boehringer Ingelheim territory manager and presented by Dr Tim Brazil BVSc, PhD, CertEM, DECEIM, MRCVS, a leading expert in equine internal medicine.
Boehringer says the presentation will help refresh veterinary professionals’ knowledge on equine lower respiratory tract disease, including Recurrent Airway Obstruction (RAO), and encourage them to feel confident and fully equipped to deal with this common respiratory scenario in practice.
During the module, attendees will be guided through two common equine respiratory cases and encouraged to discuss potential approaches to diagnosis, treatment and management in the cases he describes. The module is supported by supplementary notes which can be referred to both during and after the presentation.
Additional webinars on equine respiratory disease are also available on the Boehringer Academy website. They include: Diagnosing equine lower airway disease by Scott Pirie, Managing infectious respiratory disease by Phil Ivens, Clinical diagnostics and management of acute respiratory distress by Tim Brazil and Treatment of inflammatory airway disease by David Rendle.
To book your in-practice CPD meeting, contact your local Boehringer Ingelheim territory manager.
To view the equine respiratory disease webinars, visit www.boehringer-academy.co.uk and search for 'Inspiring CPD'.
Titled ‘The Five Steps of Seizure Management’, the sessions will update veterinary surgeons and nurses on:
Will Peel, Product Manager at TVM UK said: "The Lunch and Learn sessions have proved very popular with veterinary practices. Our aim is to update vets and nurses on diagnosis and management of epilepsy in general practice whilst educating them about products and services which can help them better support their patients."
TVM says it will also provided supporting literature, including guidelines and owner educational tools, designed to help veterinary staff in diagnosing and treating pets with epilepsy.
To book a Lunch and Learn, contact your local TVM UK territory manager or email help@tvm-uk.com.
John Alborough presented the awards at the event. Liz Rawlings from Dechra said: "It was certainly a whirlwind at this year’s LVS and we are delighted to have scooped such a prestigious award." Zoe Appleyard-Ley, Co-Founder and Managing Director at Rockster Superfood for Dogs said: "We were so excited by the response Rockster had at the London Vet Show, and thrilled to have been given the award by VetSurgeon.org."
They say that dogs which lose sensation following damage to the spinal cord from a slipped disc have a prognosis for recovery of about 50%.
However, there is no reliable way of determining which dog will recover and failing that, owners must wait weeks to months to see if there are any signs of recovery, during which time dogs may need anaesthesia, surgery, and intensive nursing care.
The researchers say that the stiffness of an organ can be a marker of how damaged it is.
So, for the research, a new ultrasound machine equipped with an advanced piece of software (known as ‘shear wave elastography’) – will be used to measure the stiffness of a dog’s spinal cord during surgery.
The dog’s recovery to walking after surgery will then be monitored routinely.
The results will allow researchers to see if a relationship between spinal cord stiffness at time of surgery and recovery exists.
If successful, this would help them provide a more accurate prognosis for dogs with spinal cord injury in the future.
If you have a case suitable for this study, CVS says they will receive a gold standard treatment for spinal cord injury, which will include spinal surgery.
They will also have an ultrasound of the spinal cord performed during surgery, a procedure taking approximately 15 minutes.
Contact referrals@highcroftvet.co.uk or nicolas.granger@bristolvetspecialists.co.uk.
BVS Neurology study from CVS (UK) Ltd on Vimeo.
Pet insurer esure has released the results of a survey of vets bills, carried out amongst 3000 pet owners.
Whilst the intent behind surveys like these may be laudable (i.e. to encourage more pet owners to insure their pets), they do the profession no favours, emphasising the high perceived costs of veterinary care rather than the good value that it generally represents.
This survey highlighted that:
esure's research showed that English Setters are the mostly costly breed of dog, forcing their owners to shell out £6,955 on vet bills, including injections, surgery and emergency treatments, in a lifetime.
Despite the potential for big bills, just a third (31 per cent) of pet owners have pet insurance and almost a quarter of those with cover admitted they were considering cancelling it to save money during the current credit crunch.
According to esure, many dog owners may be choosing to cancel or not even buy pet insurance because they are significantly underestimating the cost of treating common ailments and injuries. 29 per cent of pet owners surveyed think that the average vet bill for a dog with diabetes would be under £200, when it is actually £1146 including ongoing treatment*. To repair a dog's broken leg, 11 per cent of pet owners think that the average vet bill would be less than £100. It is actually more than five times that amount at £560*.
Mike Pickard, Head of esure pet insurance said: "Sickness, injury and long-term illness can affect any breed of dog, at any time, which is why it's crucial for pet owners to have insurance or ample savings to cover an unexpected vet bill of any size. With many pet owners underestimating the cost of treatment for common ailments, a hefty vet bill may stretch household finances to the limit - especially in the current credit crunch. Pet owners should plan ahead for all eventualities when it comes to their dog's health."
VET BILLS FOR THE TOP 10 MOST POORLY DOG BREEDS:
* Based on all claims received by pet insurance specialist, Thornside in 2008. http://www.bdml.co.uk/about-thornside.html
Woodley Equipment has launched ImmunoComb diganostic test kits for FIP, canine Leptospira and Ehrlichia
Woodley says the kits are easy to use and provide results within 20 minutes. No specialist laboratory equipment is required as the kits are self-contained with all the necessary reagents. The diagnostic kits determine the animal's antibody titre levels, in the case of the canine Ehrlichia as early as 7 days after infection, giving veterinary surgeons the opportunity to act more quickly in developing a prevention/treatment program.
Tests can be performed singly or up to 12 simultaneously.
For more information about ImmunoComb Diagnostic kits email sales@woodleyequipment.com or call: +44 (0) 1204 669033 Option 1. Alternatively visit http://www.woodleyequipment.com/
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein that is integral to the signalling pathway of cytokines that are pro-inflammatory or have a role in allergic and itch response.
According to the company, pruritus affects about one in six dogs whose owners seek veterinary help, and about half of all itchy dogs will have an underlying allergic skin condition for which the new product would be indicated.
Zoetis says that because Apoquel targets the specific pathways of pruritus (itch) and inflammation, it is less likely to cause unwanted side effects than glucocorticoids and demonstrates anti-pruritic efficacy within four hours.
Pascal Prélaud, a dermatology specialist from Paris, who took part in the clinical development programme of Apoquel, said: "When a dog develops an itch related to an allergy, it can be life-disrupting for the dog and the entire family. I've learned firsthand the fundamental difference this treatment can make to a dog and its owners in stopping the itch, but without many of the side-effects that are common with steroids.
Zoetis reports that in clinical trials, Apoquel demonstrated a good safety profile and efficacy for the treatment of pruritus and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners within 24 hours of administration, and pruritus continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinarians were significantly improved after one week and continued to improve long term during the studies (four months).
Apoquel is a POM. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium- to long-term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
The strategy, which is available to read at: www.rcvs.org.uk/diversity, lists six areas where the College and other DIG member organisations can work to improve diversity and inclusion within the veterinary professions at all stages – from school-age children who may be considering a career in the veterinary professions, to engendering positive culture change for those already in the professions.
The six areas are:
The RCVS Diversity & Inclusion Group includes representation from the Association of Veterinary Students (AVS), British Veterinary Association (BVA), the British Veterinary Ethnicity & Diversity Society (BVEDS), the British Veterinary LGBT+ Society, the British Veterinary Nursing Association (BVNA), the Major Employers Group, the Society of Practising Veterinary Surgeons (SPVS) and the Veterinary Schools Council (VSC) and will be responsible for monitoring and evaluating progress within each of the above areas.
Dr Niall Connell, Senior Vice-President of the RCVS and Chair of the Diversity & Inclusion Group, said: "I’ve always been of the opinion that making the veterinary professions more diverse and reflective of British society at large, as well as protecting fellow professionals from discrimination, isn’t just a moral issue, but one that actually improves the quality of the profession and the outcomes we are delivering for our clients and patients.
"If we are losing colleagues to discrimination or just not attracting people from diverse backgrounds in the first place because they think it’s ‘not for people like them’, then we are losing out as a profession, and if we aren’t drawing on a diverse range of backgrounds, experiences, and attitudes in our work, then we are also potentially doing a disservice to our patients and clients. This is why this Strategy is not just a case of being seen to be doing something, but is actually crucial for the ongoing vitality and credibility of the veterinary team.
"It’s important to emphasise that this Strategy is a start, and not an end in and of itself. There will be lots of hard work to be done and challenging conversations to be had, and results may not be quick or immediately obvious, but I am proud that we are taking a proactive approach and not just saying ‘things will change with time’.
Dr Mandisa Greene, RCVS President and a member of the DIG, added: “Fulfilling this Strategy will involve a lot of hard work over the coming months and years but I am glad to say that many of the activities it outlines are already underway both at the RCVS and our partner organisations, building on the pioneering work that organisations such as the British Veterinary Association, British Veterinary Ethnicity & Diversity Society, the British Veterinary LGBT+ Society, Animal Aspirations and others have been undertaking.
“For example, we have already held a joint RCVS and Veterinary Schools Council Roundtable with BAME students in which we heard about their experiences, issues that they have encountered and how they felt they could be better supported. These discussions led to the formation of a new RCVS/VSC Working Group that will take forward actions as a priority.
"Our Mind Matters Initiative has also funded a vital piece of research being undertaken by BVEDS and the Royal Veterinary College on the impact of racism on the mental health of BAME veterinary professionals which will no doubt highlight some critical actions to take to better protect members of the professions from discrimination and improve how discrimination is reported and dealt with.
“On a personal level, I have also been undertaking a number of school talks and providing one-to-one mentoring to school students about veterinary careers because I think it is important that children from a wide variety of backgrounds can see me, as a Black British woman of Caribbean heritage, as a role-model for diversity within the veterinary profession and know that the professions can and should be welcoming to all.”
Alstoe Animal Health has launched Easeflex for Cats, a mobility support supplement containing Glucosamine, Chondroitin, MSM and anti-oxidants in a palatable triangular-shaped chew.
Alstoe says stiffness in cats may be linked to changes within the synovial joints and can often go unrecognised. To help owners identify the problem, Alstoe has invented "Chedda" the Easeflex cartoon cat. The client information pack that Alstoe offers to practices consists of leaflets with graphics which outline to the owner how stiffness affects Chedda's lifestyle. .
Sales of joint supplements for cats have lagged well behind those for dogs. Alstoe says this can be explained by the difficulty in administration to chronically affected cats, but that Easeflex's unique texture, shape and flavoured base of fish and cheese, should lead to a marked improvement in compliance rates amongst pets and owners.
Easeflex for Cats is now available at wholesalers and the client information material featuring "The adventures of Chedda" is available from Alstoe by calling 01347 878606 or contacting info@alstoe.co.uk.
The course is led by Gary England, Professor of Comparative Veterinary Reproduction, University of Nottingham. Gary is an RCVS and European College of Animal Reproduction recognised Specialist in Veterinary Reproduction.
Improve says the course has been developed to address a growing interest among first opinion practitioners in developing their knowledge and skills in canine reproduction, so as to provide a higher level of service to their clients and to encourage responsible breeding.
The course will take place on 28 and 29 September at the Guide Dogs National Breeding Centre in Warwickshire.
David Babington MRCVS, Managing Director of Improve International, said: "It's unusual to find courses covering this topical subject which also include practical components. We have constructed the programme to ensure that it provides a balance between small group presentations and practical sessions with plenty of time for discussion and hands-on practice, enabling attendees to implement their new skills straight away."
Further details are available at: https://www.improveinternational.com/uk/course/canine-reproduction/
Photo: Ultrasound of dog with prostatic disease
Zoetis has announced the introduction of Equimidine solution in a 50% larger plastic bottle.
The company says the new 15ml multi-dose presentation, now in plastic rather than glass, offers greater safety, as well as cost-saving advantages to practices.
Equimidine, containing 10mg/ml detomidine hydrochloride and methyl parahydroxybenzoate 1 mg/ml as a preservative, is a clear solution for intravenous injection. It has sedative and analgesic properties and is indicated for use either alone or in combination with butorphanol to facilitate the handling of horses for clinical examinations, minor surgical procedures and other manipulations. It can also be used with ketamine for short duration general anaesthesia for surgical procedures such as castration.
According to the company, the new 15ml plastic bottle is more cost-effective per dose than the old 10ml glass vial. It is also safer to use as the bottle is less likely to break if accidentally dropped. The multi-dose facility involves a tightly fitted rubber bung through which a sterile needle can be inserted to withdraw each dose.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "The new presentation provides practical benefits for vets and the larger bottle size means the product is now even more cost-effective."
For more information, speak to your Zoetis Account Manager, refer to the SPC or contact Zoetis Customer Support on 0845 3008034.
The winners and runners up will be honoured at a ceremony taking place on the eve of BSAVA Congress on 1st April 2020.
The television presenter Matt Baker will be hosting the Ceva Animal Welfare Awards for the third consecutive year, alongside head judge Chris Laurence MBE FRCVS, who puts his name to the Vet of the Year Award.
The award categories include:
Chris Laurence Vet of the Year – sponsored by Vet Record
Vet Nurse of the Year – sponsored by Agria Pet Insurance
Charity Team of the Year – sponsored by PDSA
Charitable Contribution of the Year – sponsored by Blue Cross
International Cat Care Welfare of the Year – sponsored by International Cat Care
Farmer of the Year – sponsored by R.A.B.I. and Farmers Guardian
Farm Educator of the Year – sponsored by NADIS and Farmers Guardian
Outstanding Contribution to Animal Welfare – sponsored by Your Dog and Your Cat magazines
To nominate someone, visit wwww.cevawelfare.com. They can come from all walks of life and will be assessed on the evidence provided in the original nomination.
Entries must be in by Tuesday 31 December 2019.
The project, which is funded by the RCVS Mind Matters Initiative, is designed to find out about current attitudes, beliefs, and alcohol use behaviours of those working in clinical settings within the UK veterinary sector.
Researchers Dr Jennifer Seddon, Olivia Cormier MRCVS, and Dr Emma Davies, from Oxford Brookes University are inviting people aged 18 and over who are working in the UK veterinary sector, including vets, veterinary nurses, practice managers, veterinary care assistants, receptionists, and those undertaking other in-practice roles, who currently drink or have drunk alcohol in the past three months to take part in an online survey which takes no more than 15 minutes.
Olivia said: “Evidence from research conducted in 2009 showed that veterinary professionals may be more likely to drink at risky levels compared to people in the general population.
"There is a vital need for new research in this area, not only so we can better understand what the current situation looks like, but so that we can learn how best to provide tailored support to this group.”
The survey is anonymous and confidential, and no personal data will be gathered or shared with MMI or the RCVS.
After completing the survey, participants can choose to enter a prize draw to win one of three £100 Amazon vouchers.
https://brookeshls.co1.qualtrics.com/jfe/form/SV_0pHn8qy4ZIVTTgy
Photo: www.depositphotos.com
The BVA has welcomed the decision to prohibit the advertising of antimicrobials directly to animal keepers from 2013 in a bid to reduce antimicrobial resistance.
The Veterinary Medicines Directorate (VMD) announced that the Veterinary Medicines Regulations will be revised next year. The change has come as a result of the European Commission's view that the UK did not correctly transpose the European Directive 2001/82/EC which prohibits the advertising of certain veterinary medicinal products to the 'general public'.
When the VMD consulted on proposals to restrict the advertising of antimicrobials to farmers in 2010 the BVA supported the measure as a sensible approach to the responsible use of antimicrobials.
In a letter to stakeholders the VMD explained that: "A number of interested parties from veterinary medicine hold the view that the advertising of antibiotics to keepers of animals leads to undue pressure to prescribe newer antibiotics, which can often be important in human medicine and are associated with the development of multiple resistances."
Peter Jones, President of the BVA, said: "The BVA has consistently argued for the restriction of advertising of antimicrobials to animal keepers and we believe this is the right decision.
"New antimicrobials are heavily advertised by pharmaceutical companies and there can be undue pressure put on veterinary surgeons by clients who want to try new products that promise good results, but which may not be appropriate from the point of view of responsible use.
"Antimicrobial resistance is a very serious issue for both animal and human health and we are pleased that the European Commission and the VMD have taken the view that the Regulations need to be revised.
"Ultimately, it is the veterinary surgeon who will make the decision on which veterinary products to use and vets will continue to work with their farm clients to ensure antimicrobials are used prudently and responsibly."
The kit uses an indirect semi-quantitative IgG antibody assay which provides an easy-to-read colour change which clearly distinguishes normal IgG levels (>8mg/ml; colourless), partial FPT (4-8mg/ml; pink) and levels generally considered diagnostic of complete FPT (<4mg/ml; purple).
Vetlabs says the kit has a proven sensitivity and specificity of 97.4% and 93.6% respectively, and responds equally well with anticoagulant whole blood, serum or plasma. And with no additional equipment or refrigerated storage required, it is a true field test.
Mike Fleming, CEO of Vetlab Supplies Ltd said: "It’s not often you get to launch an equine diagnostic that’s genuinely life saving. With Fastest IgG Equine, vets can now give a clear-cut Failure of Passive Transfer (FPT) diagnosis at farms, stables or equestrian centres – and all in just 10 minutes."
According to the company, as many as 1 in 5 new-born foals can suffer some degree of IgG FPT. Foals with no antibody protection, due to complete FTP, have an estimated 75% chance of contracting debilitating or life-threatening infection. Even foals with some protection following partial FPT have only a 50% chance of resisting invaders such as Anaplasma, Giardia and Cryptosporidium.
The new-born foal’s absorption of maternal antibodies is most efficient in the first 6 to 8 hours of life, effectively ceasing after 24 to 36 hours. Veterinary surgeons and managers of equestrian facilities have only this narrow window to recognise FPT and act to save a valuable new-born from life threatening infection.
Mike added: "With Fastest Equine as part of their field kit, equine vets are equipped to diagnose and treat antibody deficient foals with life-saving colostrum, colsotrum formula substitute, or administer oral or intravenous IgG, within that critical first 24 hours."
Hosted by industry veteran, Anthony Chadwick MRCVS, there will be five episodes, covering pet life expectancy, sustainability in the vet industry, recruitment, and euthanasia.
The first episode of The Pet Profession Podcast is available now with guest Dan O’Neill, Senior Lecturer in Companion Animal Epidemiology and co-lead of the VetCompass Research Programme at the RVC, discussing pet life expectancy.
The Pet Profession Podcast is available from Spotify, Acast, Apple Podcasts and all main podcast directories.
agriapet.co.uk/vets
Vetark has launched Aqua-Sed, a fish anaesthetic which has obtained the first permit for use as a fish euthanasia product.
Vetark says the new product enables the humane euthanasia of seriously ill or severely injured fish, as well as being a sedative to facilitate fish handling.
The new product incorporates a dosing pump to ensure accurate dosing, a critical aspect of fish anaesthetics.
The 250ml bottle and pump will be on sale at £13.13+VAT and is available under the Small Animal Exemption Scheme from Vetark.
Further information on fish anaesthesia visit the Vetark website on www.vetark.co.uk
Merial has announced the launch of Viral Cats, a national campaign designed to educate one million cat owners about the importance of vaccination.
According to PDSA research, approximately 3.9 million cats in the UK are not up to date with their vaccinations and around 2.7 million cats have never been vaccinated1.
As part of the campaign, Merial is pushing a series of animations to cat owners via Facebook, which link to the campaign website: www.viralcats.co.uk. The website offers detailed information about the importance of vaccination and interactive content including a 'risk checker' quiz.
The 'risk checker' quiz will ask owners a series of questions to find out whether their cat is up to date with its vaccinations. If not, they'll be directed to speak to their vet. If the vet recommends restarting the primary vaccination course, owners will be able to download an amnesty voucher – directing them to participating practices to get their pet back on track. For those who are up-to-date with their cat’s vaccinations, but want to help spread the word, there will be a competition and prize.
Aiz Baig, product manager at Merial, said: "This campaign is really exciting for Merial, offering us a great opportunity to reach and educate cat owners on the importance of vaccination, which of course will drive footfall into practices."
There are several ways veterinary practices can get involved with the campaign:
To find out more about the campaign, or take part, contact your regional Merial Territory Manager.
References:
The study, which examined cattle farmers’ and veterinary surgeons' opinions of pain-induced distress associated with disbudding, analgesia and attitudes and the use of non-steroidal anti-inflammatory drugs (NSAIDs), suggests that in particular, vets need to refine their understanding of farmers’ priorities, and how they guide clients on methods to improve calf welfare.
There have been a number of studies into the pain-induced distress resulting from the disbudding procedure. All methods of disbudding (apart from chemical cauterisation) in the UK require the use of a corneal nerve local anaesthetic blockade but there are currently no legislative requirements for the use of NSAIDs for disbudding – it is at the discretion of the farmer or veterinary surgeon carrying out the procedure. NSAIDs are routinely used in companion animals and equine practice, but less so in farm animals.
This new study, conducted by researchers at the Royal Veterinary College (RVC) in Hertfordshire and Aran Vet Clinic in Gwynedd, looked at the attitudes of farmers and vets on pain perception and pain management methods for disbudding. A total of 118 vets and 140 farmers contributed to the study. Of the respondents:
The study concluded that veterinary surgeons underestimate the influences of welfare and analgesic duration and effectiveness on farmers' decisions, and overrated cost impact. This perception could have a negative effect on veterinary recommendation.
The authors of the study therefore advise that steps should be taken to address the current inadequacies in the communications between vets and clients in conveying the practicalities and potential benefits of using NSAIDs.
Dr Troy Gibson, PhD, PGDipSci, BSc, Lecturer in Animal Welfare Science at the Royal Veterinary College said: "Despite the large amount of evidence of the benefits of NSAIDs for disbudding, it is disappointing that their use is still not widespread. This may partly be due to the only recent licencing of one NSAID for cattle. However, from our work it is clear that one of the key barriers to wider uptake is the breakdown in communication between veterinarians and their clients in conveying the cost, practicalities and potential benefits of NSAID use for disbudding. The wider use of NSAIDs in combination with local anaesthetics during disbudding would significantly improve calf welfare."
Reference
The new app, which can be downloaded from the App Store or Google Play, gives access to the BSAVA small animal formulary, BSAVA Guide to Procedures in Small Animal Practice, the BSAVA Medicines Guide, the BSAVA Library and the Poisons Database. It also allows the user to view BSAVA CPD, podcasts and upcoming courses.
Larsson Kabukoba, BSAVA’s App Developer said: "The app content has been devised by vets, for vets and we have already received some enthusiastic feedback about how useful it is. We will continue to develop and expand the app in response to feedback from our members to make sure it changes and evolves with the times and becomes an indispensable tool for every member’s pocket."
Noelle Lowry, a marathon-running vet from Lichfield has raised almost £2,500 for the RCVS Trust in the London Marathon.
Noelle beat her fundraising target of £1,500, to raise money for the Trust to use in its work to support veterinary education and research, and in providing library and information services.
She finished 4,594 out of the 11,037 women runners in the London Marathon, taking 4 hours and 36 minutes to run the 26.2 mile long course - and beating her time last year in the New York marathon.
Noelle said: "A lot of people chipped in at the last minute - my mum has been organising people back home in Ballymena and my friends and colleagues have all put their hands in their pockets - so a huge thank you to all of them.
"I'm a great fan of the RCVS Trust. It's not one of the big charity brands but the grant funding for veterinary research can really make a difference to animals - and we can all use the library and online resources - so I wanted to give it some help."
Click here for more about the work of the RCVS Trust
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
If you're attending BEVA this September you can win a place on the CEVA-sponsored Equine Ski-PD break in January 2010, combining a couple of days of first class Continued Professional Development (CPD) with some excellent skiing in the Italian Alps.
The course runs from 13-17 January 2009 and the CPD will be spread over five sessions, equating to two-and-a-half days. Equine vets Jane Boswell, Henry Tremaine, Professor Bruce McGorum, Professor Peter Clegg and Dr Tim Brazil will cover the topics of tendonitis, wound management, ophthalmology, internal medicine and joint disease.
Skiing will be at Courmayeur, a traditional Alpine village on the Italian side of Mont Blanc, where all levels of ability, from beginners to experienced off-piste skiers, can be catered for.
To win your place, which includes flights and four nights b&b accommodation, simply visit the CEVA stand at BEVA and answer a questionnaire on Tildren®, CEVA's bisphosphonate-based treatment for equine bone disease, based on information provided via a short film loop that will be running on the stand.
For further information on equine Ski-PD contact the organisers: ben.mayes@equinevetpractice.co.uk or henry.tremaine@bristol.ac.uk
Eggshell membrane is rich in proteins and contains collagen type I, hyaluronic acid, chondroitin sulphate and glucosamine. Virbac says the components of eggshell membrane help to limit inflammatory processes that occur in osteoarthritis and preserve the existing cartilage structure whilst promoting synthesis. The company points to a study which showed that eggshell membrane contributes to a reduction in pain perception by 25%, improved joint function by 33% and increased quality of life by 35% within 6 weeks1.
Rémi Mandray, Product Manager at Virbac said: "I am delighted to be able to introduce this innovative new ingredient to the Veterinary HPM Joint & Mobility Clinical Diet. This is an addition to an already very comprehensive approach to nutrition in dogs with osteoarthritis, which affects 20% of the adult canine population2. Studies have shown that improvement on mobility is visible as quickly as 2 weeks after diet introduction3 – changing their diet truly can change their life!’
For more information contact your Virbac Territory Manager.